X
ENFR
AESA PROGRAMMES
Clinical Trial Site Platform
The online platform is currently being developed and an initial version (minimum viable product) with expedited features for COVID 19 has been made available to the public for data access and feedback gathering before the official launch at the end of the year 2020.
The platform can be accessed here
Summary of Key Features
User Profiling
Regulatory Bodies & Ethical Committee
Clinical Trial Sites
3rd Party Integration
Advisory Committee Members
An advisory committee comprising reputable experts in the clinical trials space on the African continent has been set up to advise the AAS:
David Ishola
London School of Hygiene & Tropical Medicine
Thomas Nyirenda
EDCTP, South Africa
Sameh Trabelsi
The Research Laboratory in Clinical and Experimental Pharmacology - Tunisia
Priscilla Nyambayo
Medicines Control Authority of Zimbabwe
Jerome Singh
Bioethics, CAPRISA, South Africa
Margareth Ndomondo
Sigonda-NEPAD-AUDA, South Africa
Skhumbuzo Ngozwana
Kiara Health, a CRO, South Africa
MAIGA Diadie
WHO - Afro, Congo Brazzaville
Jeanine Condo
Rwanda Biomedical Center - Rwanda
Trudie Lang
The Global Health Network (TGHN)